Fundraising Fox

Ultivue

Cambridge, US · Founded 2015 · Delaware corporation · 2 known investors

ultivue.com ↗

Vizgen provides spatial multiomics platforms that enable researchers, clinicians, and biopharma teams to map and analyze RNA and protein molecules at single-cell resolution for disease understanding and precision medicine applications. The company merged with Ultivue in 2024 to combine spatial genomics and multiplex proteomic detection capabilities.

AI & Machine LearningBiotechMedical Devicesin /vizgen@vizgen_inc

Founders & leadership

PY
Peng YinDirector
FE
Fenel EloiDirector
RC
Robert CarsonExecutive Officer, Director
PY
Peng YingExecutive Officer, Director
DR
David R. WaltExecutive Officer, Director
AJ
Andrea JacksonDirector
KC
Keith CrandellDirector

Investors · 2

ARCH Venture PartnersChicago · $50K – $250M
Northpond Venturesreported · 2 sourcesBethesda · $100K – $5Mvia Sharon Kedar · board

Reported raises · per SEC filings

Form D private placements
▶$3.3MraisedJul 2024 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrea JacksonDirector
  • Keith CrandellDirector
  • Peng YinDirector
  • Fenel EloiDirector
  • Robert CarsonExecutive Officer, Director
Offering amount
$15M
Amount sold
$3.3M
First sale
Jul 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$26.5MraisedJun 2019 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Lian Yong ChenDirector
  • Wen ChenDirector
  • David R. WaltDirector
  • Peng YinDirector
  • Sharon KedarDirector
  • Keith CrandellDirector
  • Andrew StevensonDirector
  • Michael NatanExecutive Officer, Director
Offering amount
$26.5M
Amount sold
$26.5M
First sale
Jun 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20.2MraisedFeb 2018 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David R. WaltDirector
  • Michael NatanExecutive Officer, Director
  • Wen ChenDirector
  • Andrew StevensonDirector
  • Keith CrandellDirector
  • Lian Yong ChenDirector
  • Peng YinDirector
Offering amount
$20.5M
Amount sold
$20.2M
First sale
Jul 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.2MraisedAug 2015 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peng YingExecutive Officer, Director
  • David R. WaltExecutive Officer, Director
Offering amount
$5.2M
Amount sold
$5.2M
First sale
Aug 2015
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news